#purdue-pharma

[ follow ]
#opioid-crisis
US news
fromBoston.com
4 months ago

McKinsey & Company agrees to pay $650M for helping Purdue Pharma boost opioid sales

McKinsey & Company settles with federal prosecutors for $650 million over its role in the opioid crisis, reflecting accountability for past actions.
Miscellaneous
fromwww.nytimes.com
4 months ago

McKinsey to Pay $650 Million in Opioid Settlement With Justice Department

McKinsey has settled a Justice Department investigation with a $650 million payment related to its work with Purdue Pharma during the opioid crisis.
Medicine
fromwww.theguardian.com
3 months ago

Ex-McKinsey partner pleads guilty to destroying records on opioids

A former McKinsey partner pleaded guilty to obstructing justice in relation to Purdue Pharma's opioid sales strategy.
Business
fromwww.theguardian.com
4 months ago

McKinsey to pay $650m to resolve US investigation into opioid crisis role

McKinsey acknowledges wrongdoing and pays $650 million related to the opioid epidemic settlement over five years.
Business
fromBoston.com
3 months ago

More than $100 million expected in Mass. from $7.4 billion settlement with Purdue Pharma, Sacklers

Purdue Pharma and the Sackler family have settled lawsuits for $7.4 billion over the opioid crisis, marking a significant judicial outcome.
US news
fromBoston.com
4 months ago

McKinsey & Company agrees to pay $650M for helping Purdue Pharma boost opioid sales

McKinsey & Company settles with federal prosecutors for $650 million over its role in the opioid crisis, reflecting accountability for past actions.
Miscellaneous
fromwww.nytimes.com
4 months ago

McKinsey to Pay $650 Million in Opioid Settlement With Justice Department

McKinsey has settled a Justice Department investigation with a $650 million payment related to its work with Purdue Pharma during the opioid crisis.
Medicine
fromwww.theguardian.com
3 months ago

Ex-McKinsey partner pleads guilty to destroying records on opioids

A former McKinsey partner pleaded guilty to obstructing justice in relation to Purdue Pharma's opioid sales strategy.
Business
fromwww.theguardian.com
4 months ago

McKinsey to pay $650m to resolve US investigation into opioid crisis role

McKinsey acknowledges wrongdoing and pays $650 million related to the opioid epidemic settlement over five years.
Business
fromBoston.com
3 months ago

More than $100 million expected in Mass. from $7.4 billion settlement with Purdue Pharma, Sacklers

Purdue Pharma and the Sackler family have settled lawsuits for $7.4 billion over the opioid crisis, marking a significant judicial outcome.
more#opioid-crisis
Intellectual property law
fromPatently-O
4 months ago

Federal Circuit Affirms Invalidity of Purdue's OxyContin Patents

The Federal Circuit affirmed the invalidity of Purdue Pharma's OxyContin patents due to obviousness, impacting patent law standards.
The ruling highlights the importance of analyzing inherent properties and known problems in patent obviousness evaluations.
US news
fromwww.npr.org
4 months ago

McKinsey & Company to pay $650 million for role in opioid crisis

McKinsey and Company agreed to pay $650 million to settle charges over its role in promoting OxyContin amid rising opioid crises.
fromKqed
10 months ago
SF politics

Money for California's Opioid Fight in Limbo After US Supreme Court Ruling | KQED

Negotiations in Purdue Pharma case could potentially lead to bankruptcy for Sackler family, impacting how funds will be distributed among plaintiffs.
[ Load more ]